Question 1

Does Waverly Advisors own ARKG stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Waverly Advisors holds 6,069 shares of ARKG (Ark Genomic Revolution ETF), worth $255,262.

Question 2

How many shares of ARKG does Waverly Advisors own?

Accepted Answer

As of its Q2 2026 13F, Waverly Advisors holds 6,069 shares of ARKG (Ark Genomic Revolution ETF).

Question 3

What is Waverly Advisors' ARKG position worth?

Accepted Answer

As of its Q2 2026 13F, Waverly Advisors' ARKG position is worth $255,262.

Question 4

Is Waverly Advisors buying or selling ARKG?

Accepted Answer

In Q2 2026, Waverly Advisors opened a new ARKG position of 6,069 shares.

Question 5

When did Waverly Advisors first buy ARKG?

Accepted Answer

Waverly Advisors first reported ARKG in its Q2 2019 13F and has listed it in 23 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	New	6,069	—	$255,262	0.0%	$42.06	32
2024-Q4	Exited	0	-100.0%	$0	0.0%	$23.55	0
2024-Q3	Decreased	31,428	-5.5%	$804,558	0.0%	$25.60	0